Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Orthofix Medical
OFIX
$492M
| $362K | ﹤0.01% |
11,305
-59,324
| -84% | -$1.97M |
|
3527
Amgen
AMGN
$209B
| $360K | ﹤0.01% |
1,528
-14,564
| -91% | -$3.32M |
|
3528
Accuray
ARAY
$27.5M
| $360K | ﹤0.01% |
+177,097
| New | +$369K |
|
3529
Spok Holdings
SPOK
$229M
| $360K | ﹤0.01% |
+38,492
| New | +$399K |
|
|
IDEX
3530
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $360K | ﹤0.01% |
1,434
-1,807
| -56% | -$209K |
|
|
AGTC
3531
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $360K | ﹤0.01% |
65,000
| – | – |
|
3532
RB Global
RBA
$21.5B
| $359K | ﹤0.01% |
+8,793
| New | +$360K |
|
3533
Triumph Financial Inc
TFIN
$1.81B
| $359K | ﹤0.01% |
14,807
-1,793
| -11% | -$44K |
|
3534
Silicon Laboratories
SLAB
$7.14B
| $358K | ﹤0.01% |
3,572
-86,514
| -96% | -$8.09M |
|
3535
Gogo Inc
GOGO
$525M
| $356K | ﹤0.01% |
+112,771
| New | +$242K |
|
|
AXDX
3536
DELISTED
Accelerate Diagnostics
AXDX
| $355K | ﹤0.01% |
2,345
-242
| -9% | -$23.9K |
|
3537
BCE
BCE
$20.8B
| $355K | ﹤0.01% |
8,491
-37,992
| -82% | -$1.56M |
|
3538
Invesco
IVZ
$12.4B
| $355K | ﹤0.01% |
32,979
-1,047,724
| -97% | -$9.4M |
|
|
GSS
3539
DELISTED
Golden Star Resources Ltd.
GSS
| $355K | ﹤0.01% |
+122,477
| New | +$318K |
|
|
ENZ
3540
DELISTED
Enzo Biochem, Inc.
ENZ
| $354K | ﹤0.01% |
157,855
+29,935
| +23% | +$77K |
|
|
RIVE
3541
DELISTED
Riverview Financial Corporation Common Stock
RIVE
| $354K | ﹤0.01% |
65,849
+1,717
| +3% | +$10.2K |
|
|
CIIC
3542
DELISTED
CIIG Merger Corp. - Class A Common Stock
CIIC
| $354K | ﹤0.01% |
35,756
-14,244
| -28% | -$139K |
|
3543
Bank7 Corp
BSVN
$479M
| $353K | ﹤0.01% |
32,538
-37,049
| -53% | -$342K |
|
3544
Invesco Senior Loan ETF
BKLN
$6.96B
| $351K | ﹤0.01% |
+16,420
| New | +$347K |
|
3545
United Microelectronic
UMC
$42.9B
| $351K | ﹤0.01% |
132,945
+92,728
| +231% | +$233K |
|
3546
Invesco S&P 500 Quality ETF
SPHQ
$19B
| $349K | ﹤0.01% |
+9,853
| New | +$334K |
|
3547
Alpha Pro Tech
APT
$49.9M
| $348K | ﹤0.01% |
19,653
+4,581
| +30% | +$63.3K |
|
3548
BlackBerry
BB
$4.58B
| $345K | ﹤0.01% |
70,496
-430,874
| -86% | -$1.95M |
|
3549
Everspin Technologies
MRAM
$303M
| $344K | ﹤0.01% |
48,976
+22,389
| +84% | +$110K |
|
|
OPOF
3550
DELISTED
Old Point Financial
OPOF
| $344K | ﹤0.01% |
22,576
-1,263
| -5% | -$19.7K |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.